Arzerra

Made by

• GlaxoSmithKline

Active Ingredient

Ofatumumab

Prospectus

Approval date

2013/3/25

Treats

• Multiple sclerosis
• Chronic lymphocytic leukemia

Dosages

• Arzerra for I.V.infusion - 28904円／瓶

• Arzerra for I.V.infusion - 280240円／瓶